LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- -
- Market Cap
- -
Effect of Colchicine on Progression of Known Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease
- First Posted Date
- 2024-04-02
- Last Posted Date
- 2024-10-14
- Target Recruit Count
- 84
- Registration Number
- NCT06342609
- Locations
- 🇺🇸
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, California, United States
Study of Cannabidiol in Sanfilippo Syndrome
- Conditions
- Interventions
- First Posted Date
- 2024-03-27
- Last Posted Date
- 2024-10-22
- Target Recruit Count
- 35
- Registration Number
- NCT06333041
- Locations
- 🇺🇸
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
- Conditions
- Interventions
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2024-12-05
- Target Recruit Count
- 180
- Registration Number
- NCT05753215
- Locations
- 🇺🇸
The Lundquist Institute For Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States
Diet-induced Elevations in LDL-C and Progression of Atherosclerosis
- Conditions
- First Posted Date
- 2023-02-17
- Last Posted Date
- 2024-03-19
- Target Recruit Count
- 100
- Registration Number
- NCT05733325
- Locations
- 🇺🇸
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance, California, United States
Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- Conditions
- Interventions
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Matthew J. Budoff
- Target Recruit Count
- 120
- Registration Number
- NCT05708859
- Locations
- 🇺🇸
Lundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center (The Lundquist Institute), Torrance, California, United States
Long Haul COVID Rehabilitation & Recovery Research Program
- Conditions
- Interventions
- First Posted Date
- 2022-06-01
- Last Posted Date
- 2024-07-01
- Target Recruit Count
- 40
- Registration Number
- NCT05398692
- Locations
- 🇺🇸
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, United States
Intravenous N-Acetylcysteine for the Treatment of Acute Ischemic Stroke
- First Posted Date
- 2021-06-09
- Last Posted Date
- 2021-06-11
- Target Recruit Count
- 118
- Registration Number
- NCT04918719
Prevention of Obesity in Infants of Overweight and Obese Women
- Conditions
- Interventions
- First Posted Date
- 2021-03-04
- Last Posted Date
- 2022-02-22
- Target Recruit Count
- 240
- Registration Number
- NCT04782063
- Locations
- 🇺🇸
Penn State College of Medicine, Hershey, Pennsylvania, United States
Determine if Human Infant Weight Gain Can be Modulated to Prevent Obesity
- Conditions
- Interventions
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2023-07-10
- Target Recruit Count
- 100
- Registration Number
- NCT04526860
- Locations
- 🇧🇷
Breastfeeding Center Ana Abrao, Federal of São Paulo University, Brazil, Sao Paulo, San Paulo, Brazil
Comparison of Two Application Techniques for LET Gel
- Conditions
- Interventions
- First Posted Date
- 2019-12-18
- Last Posted Date
- 2021-02-18
- Target Recruit Count
- 48
- Registration Number
- NCT04203225
- Locations
- 🇺🇸
Children's Hospital of Orange County, Orange, California, United States
🇺🇸Harbor-UCLA Medical Center, Torrance, California, United States